J. Chen et al. / Tetrahedron Letters 54 (2013) 1572–1575
1575
group is well tolerated in this reaction and in fact does not need to
be protected. (Table 2, entries 4, 12, and 15).13 Moreover,
-azido
Supplementary data
a
ketones with alkyl substituents (Table 2, entry 10) and heterocyclic
substituents (Table 2, entries 9 and 17) were obtained in the same
reaction condition in good isolated yields, excluding entry 14.
On the basis of the results presented above, we proposed the
Supplementary data associated with this article can be found, in
References and notes
possible mechanism in Scheme 1. Reaction of the starting a-azido
ketones (I) and potassium ethylxanthate (II) affords the imino
intermediate (IV) with a molecule of N2 lost. The reaction is be-
lieved to involve the dimerization of the imino intermediate (IV)
followed by dehydration. Two isomers (a and b) can be generated
via [1,5]-hydrogen shift as shown in Scheme 1.11
1. (a) Yang, C.; Lee, H. M.; Nolan, S. P. Org. Lett. 2011, 3, 1511; (b) Herrmann, W. A.
Angew. Chem., Int. Ed. 2002, 41, 1290; (c) Zhao, Y.; Zhou, Y.; Ma, D.; Liu, J.; Li, L.;
Zhang, T. Y.; Zhang, H. Org. Biomol. Chem. 2003, 1, 1643.
2. Bao, W.; Wang, Z.; Li, Y. J. Org. Chem. 2003, 68, 591.
3. (a) Faulkner, D. J. Nat. Prod. Rep. 2000, 17, 7; (b) Ho, J. Z.; Hohareb, R. M.; Ahn, J.
H.; Sim, T. B.; Rapoport, H. J. Org. Chem. 2003, 68, 109.
Furthermore, we carried out a ‘mix’ experiment between 2-azi-
do-1-phenylethanone and 2-azido-1-(4-hydroxy phenyl)ethanone
(Scheme 2). The experimental reaction resulted in the production
of four products. The ratio was determined by HPLC.
In conclusion, we report an efficient, novel procedure for the
synthesis of new imidazole derivatives. This reaction was realized
4. Grimmett, M. R. In Comprehensive Heterocyclic Chemistry II; Katritsky, A. R.,
Scriven, E. F. V., Eds.; Pergamon: Oxford, 1996; Vol. 3, pp 77-220.
5. Kawasaki, L.; Yamashita, M.; Ohta, S. Chem. Pharm. Bull. 1996, 1831, 44.
6. (a) Maier, T.; Schmierer, R.; Bauer, K.; Bieringer, H.; Buerstell, H.; Sachser, B.
German Patent 317,094, 1983.; (b) Scmierer, R.; Mildenberger, H.; Buerstell, H.
German Patent 3,614,364, 1987.; (c) Schmierer, R.; Mildenberger, H.; Buerstell,
H. Chem. Abstr. 1988, 108, 37838.
7. (a) Lo, Y. S.; Nolan, J. C.; Maren, T. H.; Welstead, W. J., Jr.; Gripshover, D. F.;
Shamblee, D. A. J. Med. Chem. 1992, 35, 4790; (b) Bhat, N. R.; Zhang, P. S.;
Mohanty, S. B. Neurochem. Res. 2007, 32, 293.
8. (a) Heers, J.; Backx, L. J. J.; Mostmans, J. H.; Van Cutsem, J. J. Med. Chem. 1979,
22, 1003; (b) Tanigawara, Y.; Aoyama, N.; Kita, T.; Shirakawa, K.; Komada, F.;
Kasuga, M.; Okumura, K. Clin. Pharmacol. Ther. 1999, 66, 528.
9. (a) Lombardino, J. G.; Wiseman, E. H. J. Med. Chem. 1974, 17, 1182; (b)
Lombardino, J. G. Ger offen 2,155,558, 1972.
through the condensation of readily available
a-azido ketones in
the presence of potassium ethylxanthate as a catalyst in good
yields. Moreover it is economical in atom count as only a molecule
of nitrogen is lost in the entire process.
10. (a) Durán, R.; Zubía, E.; Ortega, M. J.; Naranjo, S.; Salyá, J. Tetrahedron 1999, 55,
13225; (b) Manzanaro, S.; Salvá, J.; De la Feunte, J. A. J. Nat. Prod. 2006, 69,
1485.
Acknowledgments
11. (a) Khalili, B.; Tondro, T.; Hashemi, M. M. Tetrahedron 2009, 65, 6882; (b)
Zuliani, V.; Cocconcelli, G.; Fantini, M.; Ghiron, C.; Rivara, M. J. Org. Chem. 2007,
72, 4551.
12. (a) Batanero, B.; Escudero, J.; Barba, F. Org. Lett. 1999, 1, 1521; (b) Benati, L.;
Leardini, R.; Minozzi, M.; Nanni, D.; Spagnolo, P.; Strazzari, S.; Zanardi, G.;
Calestani, G. Tetrahedron 2002, 58, 3485.
We would like to thank The Project of Science Technology
Department of Zhejiang Province (2012C33065), the Program for
Zhejiang Leading Team of S&T Innovation (2011R50014), and Pro-
ject of Education Department of Zhejiang Province (Y201223193)
for funding this work. The work was supported by Diabetes Na-
tional Reseach Group, Inc.
13. Mahboobi, S.; Sellmer, A.; Burgemeister, T.; Lyssenko, A.; Schollmeyer, D.
Monatsh. Chem. 2004, 135, 333.